Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • MDI Biological Laboratory to Sponsor 'Live Longer, Live Better' Lecture Series

    Jul 23, 2018, 14:50 PM by Michael Croft
    BAR HARBOR, ME, UNITED STATES - Jul 23, 2018 - How close is medicine to an anti-aging pill? Can anti-aging therapies delay the onset of age-related degenerative diseases? What lifestyle choices can individuals make to prolong healthy lifespan?These are some of the tantalizing questions that will be addressed in a lecture series for the public by leading scientists in the field of aging research entitled “Live Longer, Live Better
    Full story
  • Eight New Mouse Models For Alzheimer’s Disease Available To Researchers

    Jul 23, 2018, 14:20 PM by Michael Croft

    Bio-IT World Brief | The MODEL-AD Center, an ambitious project to develop and distribute precise mouse models of late-onset Alzheimer’s disease (AD), has released eight new models carrying genetic mutations found in patients.

    Full story
  • Human Longevity Blasts Craig Venter, Claiming He Was Fired, Then Stole Trade Secrets — Poaching Staffers For Rival Operation

    Jul 23, 2018, 10:28 AM by Michael Croft
    Endpoints News | On Friday, Human Longevity filed suit against ex-CEO and executive chairman Craig Venter, claiming that Venter had stolen trade secrets, recruited staffers, and planned to set up a rival organization.
    Full story
  • Qlucore Omics Explorer used in analyses of human protein arrays

    Jul 23, 2018, 05:54 AM by Michael Croft
    LUND, SWEDEN - Jul 23, 2018 - Qlucore Omics Explorer used in analyses of human protein arrays Qlucore, a world leader in the development of bioinformatics software, is pleased to announce a licence contract with Cambridge Protein Arrays Ltd Cambridge Protein Arrays Ltd
    Full story
  • CD GENOMIC Reaches a New High in Simplifying Genome Sequencing Technique: 2b-RAD

    Jul 23, 2018, 05:24 AM by Michael Croft
    NEW YORK, NY, UNITED STATES - Jul 23, 2018 - CD Genomic Company is able to provide the 2b-RAD technique, the upgraded RAD technique to simplify genome sequencing technique thereby achieving genome-wide high-throughput SNP genotyping
    Full story
  • VA, IBM Extend Watson For Genomics Partnership

    Jul 19, 2018, 11:10 AM by Michael Croft

    Bio-IT World Brief | Today the US Department of Veterans Affairs and IBM Watson Health announced the extension of a public-private partnership to apply artificial intelligence to help interpret cancer data in the treatment of Veteran patients.

    Full story
  • Quartzy Opens Second Distribution Warehouse, Expanding Options To Serve Software Customers

    Jul 19, 2018, 09:15 AM by Michael Croft

    Bio-IT World | Quartzy, a free online laboratory supply management and ordering platform, has expanded distribution operations with a new 40,000 square foot warehouse in Hayward, California, and grown its lab supply portfolio to over three million SKUs.

    Full story
  • Domainex opens for business in Boston and San Diego

    Jul 19, 2018, 05:23 AM by Michael Croft
    CAMBRIDGE, UK - Jul 19, 2018 - Domainex Ltd, Europe’s fastest growing drug discovery service company, is pleased to announce its expansion to the US with the appointment of a new business development team and the opening of East and West coast offices in Boston, MA and San Diego, CA
    Full story
  • Aircuity Highlights Platform for Reducing Energy Use and Improving the Indoor Environment at the NACUBO 2018 Annual Meeting

    Jul 18, 2018, 14:26 PM by Michael Croft
    NEWTON, MA, UNITED STATES - Jul 18, 2018 - Aircuity, (www.aircuity.com), creator of measurably better environments, will be highlighting the benefits of its platform for optimizing ventilation at universities during the National Association of College and University Business Officers’ NACUBO 2018 Annual Meeting
    Full story
  • Tetraphase Selects SHYFT To Support Data And Analytics For Commercial Launch Readiness

    Jul 18, 2018, 14:00 PM by Michael Croft

    Bio-IT World Brief | SHYFT Analytics announced Tetraphase has selected its platform to support the anticipated commercial launch of eravacycline, its lead antibiotic candidate developed to address multidrug-resistant bacteria.

    Full story
  • AWS Unveils New HPC Instances With Fast Cores

    Jul 18, 2018, 09:39 AM by Michael Croft
    TOP500 | Amazon Web Services has announced a new set of instances designed for applications that can benefit from high core performance.
    Full story
  • Creative Biolabs Established a Comprehensive Phage Display Systems for Lab Use

    Jul 17, 2018, 23:49 PM by Michael Croft
    SHIRLEY, NY - Jul 18, 2018 - July 17, 2018, with decades of experience, Creative Biolabs has extensive expertise in various antibody production and engineering fields
    Full story
  • IVD Raw Materials Are Launched by Creative Diagnostics for bio-researchers

    Jul 17, 2018, 23:45 PM by Michael Croft
    SHIRLEY, NY, UNITED STATES - Jul 18, 2018 - As a global leader in the manufacture of raw materials, reagents and antibodies for biotechnology industry, Creative Diagnostics recently launches varieties of IVD raw materials to the global marketplace for life science applications
    Full story
  • Verodin Closes $21M Series B Financing to Capture Global Demand for Cybersecurity Effectiveness

    Jul 17, 2018, 18:49 PM by Michael Croft
    MCLEAN, VA - Jul 17, 2018 -  Verodin, the leader in validating the effectiveness of cybersecurity controls, today announced $21M in Series B funding led by TenEleven Ventures and Bessemer Venture Partners (BVP)
    Full story
  • Genstar Capital to Acquire CRF Health from Vitruvian Partners and Combine with Bracket

    Jul 17, 2018, 15:30 PM by Michael Croft
    , PA - Jul 17, 2018 - London, United Kingdom and Wayne, Pennsylvania, USA - Genstar Capital, a leading investor in healthcare technology and services companies, is pleased to announce the acquisition of CRF Health, a global provider of eCOA and eConsent solutions for the life sciences industry
    Full story
  • ZEISS expands X-ray imaging portfolio with ZEISS Xradia Context microCT

    Jul 17, 2018, 10:19 AM by Michael Croft
    JENA, GERMANY - Jul 17, 2018 - Built on renowned ZEISS Xradia platform and field-convertible to ZEISS Xradia Versa X-ray microscopeJENA/GermanyZEISS introduces a new X-ray imaging instrument, ZEISS Xradia Context microCT, a large field-of-view, non-destructive 3D X-ray microcomputed tomography system
    Full story
  • Sekisui XenoTech Receives New US Patent for Kit and Method to Evaluate Xenobiotic Drug Metabolism in Hepatocytes

    Jul 17, 2018, 08:49 AM by Michael Croft
    KANSAS CITY, KS, UNITED STATES - Jul 17, 2018 - Sekisui XenoTech has been awarded US patent # 10,001,471 "In vitro test system to evaluate xenobiotics as immune-modulators of drug transport and metabolism in human hepatocytes
    Full story
  • Government Insurers Balk At Paying For CAR-T Cancer Drug

    Jul 17, 2018, 08:44 AM by Michael Croft
    NPR | Treatment costs for the immunotherapy can run to more than $1 million. Some state Medicaid programs aren't paying for the treatment, and Medicare's complicated payment rates have hospitals worried.
    Full story
  • Inflection Biosciences Announces Publication of Positive Data for Dual Mechanism Inhibitor Against Chronic Lymphocytic Leukaemia

    Jul 17, 2018, 05:30 AM by Michael Croft
    DUBLIN, IRELAND - Jul 17, 2018 - Inflection Biosciences Ltd, a private company developing innovative therapeutics for cancer, today announced the publication of preclinical data showing the company’s dual mechanism PIM/PI3 kinase inhibitor IBL-202 has promise as a treatment for chronic lymphocytic leukaemia (CLL)
    Full story
  • Another CRISPR Calamity? U.K. Team Reports CRISPR-Induced Gene Rearrangements

    Jul 16, 2018, 12:38 PM by Michael Croft
    GEN | Scientists at the Wellcome Sanger Institute in the U.K. have reported another potential hurdle for the CRISPR community, publishing findings today that call the precision of CRISPR-Cas9 gene editing into question.
    Full story
  • «
  • 261
  • 262
  • 263
  • 264
  • 265 (current)
  • 266
  • 267
  • 268
  • 269
  • 270
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy